Acadian Asset Management LLC Biogen Inc. Transaction History

Acadian Asset Management LLC

  • $32.2 Billion
  • Q3 2024

A detailed history of Acadian Asset Management LLC transactions in Biogen Inc. stock. As of the latest transaction made, Acadian Asset Management LLC holds 2,458 shares of BIIB stock, worth $394,828. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,458
Previous 5,702 56.89%
Holding current value
$394,828
Previous $1.32 Million 63.94%
% of portfolio
0.0%
Previous 0.0%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
SELL
$189.07 - $236.8 $613,343 - $768,179
-3,244 Reduced 56.89%
2,458 $476,000
Q2 2024

Aug 06, 2024
BUY
$190.52 - $236.72 $726,452 - $902,613
3,813 Added 201.85%
5,702 $1.32 Million
Q1 2024

May 10, 2024
SELL
$212.02 - $267.71 $8,056 - $10,172
-38 Reduced 1.97%
1,889 $407,000
Q4 2023

Feb 13, 2024
SELL
$222.59 - $267.94 $2.54 Million - $3.05 Million
-11,398 Reduced 85.54%
1,927 $497,000
Q3 2023

Nov 13, 2023
SELL
$253.3 - $285.89 $8.29 Million - $9.35 Million
-32,715 Reduced 71.06%
13,325 $3.42 Million
Q2 2023

Aug 07, 2023
BUY
$275.25 - $318.06 $104,870 - $121,180
381 Added 0.83%
46,040 $13.1 Million
Q1 2023

May 11, 2023
SELL
$256.56 - $292.34 $3.58 Million - $4.08 Million
-13,962 Reduced 23.42%
45,659 $12.7 Million
Q4 2022

Feb 14, 2023
SELL
$252.44 - $306.72 $8.16 Million - $9.92 Million
-32,332 Reduced 35.16%
59,621 $16.5 Million
Q3 2022

Nov 14, 2022
BUY
$194.69 - $268.46 $3.29 Million - $4.53 Million
16,878 Added 22.48%
91,953 $24.5 Million
Q3 2022

Nov 14, 2022
BUY
$194.69 - $268.46 $3.29 Million - $4.53 Million
16,878 Added 22.48%
91,953 $24.5 Million
Q2 2022

Aug 09, 2022
SELL
$187.54 - $223.02 $7.4 Million - $8.8 Million
-39,465 Reduced 34.46%
75,075 $15.3 Million
Q1 2022

May 12, 2022
BUY
$193.77 - $244.14 $16.8 Million - $21.2 Million
86,746 Added 312.1%
114,540 $24.1 Million
Q4 2021

Feb 10, 2022
SELL
$223.92 - $287.77 $9.71 Million - $12.5 Million
-43,381 Reduced 60.95%
27,794 $6.67 Million
Q3 2021

Nov 12, 2021
SELL
$282.99 - $369.05 $30.6 Million - $39.9 Million
-108,046 Reduced 60.29%
71,175 $20.1 Million
Q2 2021

Aug 11, 2021
SELL
$259.0 - $414.71 $44.4 Million - $71.1 Million
-171,511 Reduced 48.9%
179,221 $62.1 Million
Q1 2021

May 11, 2021
SELL
$242.95 - $284.63 $37 Million - $43.4 Million
-152,468 Reduced 30.3%
350,732 $98.1 Million
Q4 2020

Feb 11, 2021
SELL
$236.26 - $355.63 $4.99 Million - $7.51 Million
-21,114 Reduced 4.03%
503,200 $123 Million
Q3 2020

Nov 09, 2020
BUY
$264.77 - $305.71 $37.1 Million - $42.8 Million
140,012 Added 36.43%
524,314 $149 Million
Q2 2020

Aug 12, 2020
BUY
$258.66 - $342.55 $77.6 Million - $103 Million
299,950 Added 355.59%
384,302 $103 Million
Q1 2020

May 11, 2020
BUY
$268.85 - $341.04 $21.9 Million - $27.8 Million
81,577 Added 2939.71%
84,352 $26.7 Million
Q3 2019

Nov 07, 2019
SELL
$217.44 - $243.88 $246,576 - $276,559
-1,134 Reduced 29.01%
2,775 $646,000
Q1 2019

May 09, 2019
SELL
$216.71 - $338.96 $2.01 Million - $3.14 Million
-9,252 Reduced 70.3%
3,909 $924,000
Q4 2018

Feb 07, 2019
SELL
$278.5 - $352.75 $30.4 Million - $38.5 Million
-109,257 Reduced 89.25%
13,161 $3.96 Million
Q3 2018

Oct 30, 2018
BUY
$293.51 - $383.83 $34.4 Million - $44.9 Million
117,069 Added 2188.61%
122,418 $43.3 Million
Q2 2018

Jul 24, 2018
SELL
$257.52 - $306.91 $3.16 Million - $3.77 Million
-12,279 Reduced 69.66%
5,349 $1.55 Million
Q1 2018

Apr 12, 2018
BUY
$260.13 - $367.91 $2.14 Million - $3.03 Million
8,243 Added 87.83%
17,628 $4.83 Million
Q4 2017

Jan 18, 2018
BUY
$307.64 - $344.58 $741,104 - $830,093
2,409 Added 34.53%
9,385 $2.99 Million
Q3 2017

Oct 13, 2017
BUY
$281.15 - $329.69 $1.96 Million - $2.3 Million
6,976
6,976 $2.19 Million

Others Institutions Holding BIIB

# of Institutions
1,037
Shares Held
126M
Call Options Held
1.13M
Put Options Held
1.43M
View Full List

About BIOGEN INC.

BIIB Quotes by TradingView
  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $23.1B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Acadian Asset Management LLC Portfolio

Follow Acadian Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acadian Asset Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email